04 Dec 2023
Clinic’s data breach reminder to bolster security
The personal details of more than 5000 patients may have been ‘compromised’ after a Brisbane medical centre’s email account was breached.
04 Dec 2023
Ear health improving for First Nations people: AIHW
A new report shows the rates of ear and hearing problems have declined, while screening and audiology uptake have improved.
04 Dec 2023
ASTHMA AUSTRALIA WELCOMES RELEASE OF NATIONAL HEALTH AND CLIMATE STRATEGY AND TRANSITION TO QUALITY, LOW-CARBON ASTHMA CARE
The Australian Government released its first National Health and Climate Strategy today. Asthma Australia welcomes the Strategy, which commits to supporting healthy, climate-resilient communities as well as a net-zero health system.
04 Dec 2023
New program increases Victorian community’s access to free naloxone
Victoria is launching the Take-Home Naloxone Program to increase community access to naloxone, a life-saving medication that reverses opioid overdose.
04 Dec 2023
Tribunal reprimands and cancels nurse/midwife's registration after her conviction for child exploitation offences
A Western Australian nurse/midwife convicted of child exploitation offences has been reprimanded by a tribunal, had her registration cancelled and been disqualified from applying for registration for five years.
04 Dec 2023
Launch of Australia’s first National Health and Climate Strategy
The Australian Government has launched Australia’s first National Health and Climate Strategy.
01 Dec 2023
PBS arrangements due to discontinuation of the Ordine brands of morphine hydrochloride trihydrate oral liquids effective 1 December 2023
Two new temporarily PBS listings for morphine sulfate will be effective from 1 December 2023. These new products are being listed to address the deletion from the Australian market of morphine hydrochloride trihydrate oral liquids (brand: Ordine).
01 Dec 2023
1 December 2023 Changes to the PBS Listings of Medicines for the Treatment of Ankylosing Spondylitis
On 1 December 2023, changes will be made to the authority requirements of the following biological medicines listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of ankylosing spondylitis – adalimumab, etanercept and infliximab.
01 Dec 2023
PBS Safety Net early supply for 60-day prescriptions
PBS Safety Net early supply for 60-day prescriptions
01 Dec 2023
Updates to the HTA Policy and Methods Review Reference Committee – 1 December 2023
To ensure that the Reference Committee has sufficient time to consider the extensive and valuable input and material received for the HTA Review so far, as well as conduct further public consultation, the HTA Review has been extended until 15 April 2024.